mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.2 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |